NeuroTalk Support Groups

NeuroTalk Support Groups (https://www.neurotalk.org/)
-   New Member Introductions (https://www.neurotalk.org/new-member-introductions/)
-   -   Help Read Results (https://www.neurotalk.org/new-member-introductions/256607-help-read-results.html)

asolive 04-13-2021 10:39 AM

Help Read Results
 
Hello, I'm not sure if I'm doing this correctly or posting in the correct place. I just wanted help translating my brain MRI results to layman terms. Thanks so much

FINDINGS:
Again seen but decrease in size is the previously described deep right frontal white matter lesion adjacent to the anterior right lateral ventricle. Lesion is decreased in size from 22 x 17 mm to 16 x 12 mm and is central high signal on T2/FLAIR images and decreased signal on T1-weighted images but mild central T2 increase enhancement. It does not demonstrate restricted diffusion. There is modest central enhancement. There is a surrounding hemosiderin ring and hemosiderin central stain seen. Susceptibility is images suggest possible vessel extending into this region. Given the clinical history of the findings consistent with a bleeding AVM and intermittent minimal central acute hemorrhage is suggested by subtly increasing central T1 signal and development of central enhancement. Probability of low-grade malignancy appears low but cannot be ruled out.
As noted on prior studies there is susceptibility dropout consistent with prior hemorrhage seen involving focal areas of the right occipital lobe, left frontal, right temporal and right frontal vertex consistent with history of prior AVM bleeding.
Ventricular system is unremarkable. No evidence of acute ischemic change/CVA. Unremarkable spine-medullary junction. Unremarkable orbits. Unremarkable calvarium. Unremarkable mastoid air cells. Bilateral maxillary and ethmoid sinusitis as well as right sphenoid disease.

IMPRESSION : Decreasing size of the currently 1.6 x 1.2 cm lesion involving the deep right frontal white matter compared with study of 2012. There is subtle suggestion of some central bleed with mildly increased T1 signal and interval development of some central enhancement new since prior study. Susceptibility imaging demonstrating evidence of hemosiderin stain and surrounding hemosiderin ring. Given the clinical history, the findings appear to represent an involuting AVM which may have developed some central hemorrhage accounting for current central enhancement.
Multiple scattered bilateral punctate areas of cerebral susceptibility dropout consistent with hemosiderin staining secondary prior AVM bleeds consistent with clinical history..

Kitt 04-13-2021 01:41 PM

Welcome asolive. :Tip-Hat: Someone will be along.

Lara 04-13-2021 10:21 PM

Hi asolive,
Welcome to NeuroTalk Support Groups.

Sorry not to be able to help but that's a pretty complex result and best told to you by your doctor.

Hopefully you don't have to wait too long for your next doctor's visit. If you're very concerned maybe phone the office and see if they can organize a Telehealth appointment if you have those there.

I'm hoping they get back to you asap.

take care there.

kiwi33 04-13-2021 10:57 PM

Hi asolive

Welcome to NeuroTalk :).

One thing to bear in mind is that you can use the Search option here (https://www.neurotalk.org/search.php) to find topics and thread which could help you.

Best wishes.

Jomar 04-14-2021 12:54 AM

Quote:

Originally Posted by asolive (Post 1292991)
Hello, I'm not sure if I'm doing this correctly or posting in the correct place. I just wanted help translating my brain MRI results to layman terms. Thanks so much

FINDINGS:
Again seen but decrease in size is the previously described deep right frontal white matter lesion adjacent to the anterior right lateral ventricle. Lesion is decreased in size from 22 x 17 mm to 16 x 12 mm and is central high signal on T2/FLAIR images and decreased signal on T1-weighted images but mild central T2 increase enhancement. It does not demonstrate restricted diffusion. There is modest central enhancement. There is a surrounding hemosiderin ring and hemosiderin central stain seen. Susceptibility is images suggest possible vessel extending into this region. Given the clinical history of the findings consistent with a bleeding AVM and intermittent minimal central acute hemorrhage is suggested by subtly increasing central T1 signal and development of central enhancement. Probability of low-grade malignancy appears low but cannot be ruled out.
As noted on prior studies there is susceptibility dropout consistent with prior hemorrhage seen involving focal areas of the right occipital lobe, left frontal, right temporal and right frontal vertex consistent with history of prior AVM bleeding.
Ventricular system is unremarkable. No evidence of acute ischemic change/CVA. Unremarkable spine-medullary junction. Unremarkable orbits. Unremarkable calvarium. Unremarkable mastoid air cells. Bilateral maxillary and ethmoid sinusitis as well as right sphenoid disease.

IMPRESSION : Decreasing size of the currently 1.6 x 1.2 cm lesion involving the deep right frontal white matter compared with study of 2012. There is subtle suggestion of some central bleed with mildly increased T1 signal and interval development of some central enhancement new since prior study. Susceptibility imaging demonstrating evidence of hemosiderin stain and surrounding hemosiderin ring. Given the clinical history, the findings appear to represent an involuting AVM which may have developed some central hemorrhage accounting for current central enhancement.
Multiple scattered bilateral punctate areas of cerebral susceptibility dropout consistent with hemosiderin staining secondary prior AVM bleeds consistent with clinical history..

I bolded a few things to make it easier to read and you can look up any words you don't know.. it will be good to know what they are when talking with drs..


All times are GMT -5. The time now is 03:01 AM.

Powered by vBulletin • Copyright ©2000 - 2024, Jelsoft Enterprises Ltd.

vBulletin Optimisation provided by vB Optimise v2.7.1 (Lite) - vBulletin Mods & Addons Copyright © 2024 DragonByte Technologies Ltd.